市場調查報告書
商品編碼
1454055
輻射劑量市場至2030年的預測:按產品類型、應用、最終用戶和地區的全球分析Radiation Dose Market Forecasts to 2030 - Global Analysis By Product Type (Dosimeters, Radiation Detection and Monitoring Devices, Radiation Measurement Instruments and Other Product Types), Application, End User and By Geography |
根據 Stratistics MRC 的資料,預測期內全球輻射劑量市場的年複合成長率為 13.2%。
輻射劑量是指物體和生物暴露於電離輻射時所吸收的能量量。它以Gray(GY)和Sievert(SV)等單位進行測量。劑量對於評估輻射暴露的潛在生物效應非常重要。由於不同的組織和器官對輻射的敏感性不同,因此了解輻射計量對於評估風險和確定適當的安全措施非常重要。輻射劑量監測和控制對於確保醫療診斷、治療、工業應用和環境保護的安全並最大程度地減少潛在危害非常重要。
據世界衛生組織(WHO)表示,到2023年 1月,低收入和中等收入國家的近 10 億人將在電力很少或根本沒有電力的醫療機構中接受護理。
輻射安全意識不斷增強
醫療機構越來越重視輻射安全工作並投資劑量監測技術,以確保符合監管標準並改善病患治療結果。此外,患者在醫學影像處理中越來越積極地倡導自身安全。在教育措施、監管指南和公共衛生傳播進步的推動下,人們的認知不斷提高,推動市場擴張。
實施成本高
需要專門的設備和技術來測量和監測輻射劑量是主要成本因素之一。這些儀器的購買成本很高,而且它們的維護和校準會增加持續的成本。此外,維護、校準和軟體更新的持續成本進一步增加了財務負擔。特別是在面臨財政限制和資源有限的醫療保健系統中,這些費用可能會對本已緊張的預算造成壓力,阻礙該市場的發展。
技術進步
感測器技術、資料分析和影像處理軟體的創新使得更先進的輻射劑量監測設備和系統的開發成為可能。這些技術的發展不僅透過最大限度地減少不必要的輻射暴露來提高病患的安全,而且還提高了醫護人員的工作流程效率和資料管理。此外,影像處理軟體的改進將有助於劑量追蹤和分析,可以全面評估體內輻射劑量分佈,進一步推動該市場的發展。
缺乏意識和教育
缺乏認知和教育可能導致輻射劑量監測技術的利用不足、錯過劑量最佳化的機會以及患者和醫療保健專業人員發生輻射相關副作用的風險增加。此外,患者可能沒有充分了解包括電離輻射的醫學影像的風險和益處,這是市場擴張的主要障礙。
COVID-19 的影響
COVID-19 的爆發對全球輻射劑量市場產生了一些負面影響。其中一項重大影響是常規醫療保健服務的中斷,包括乳房X光攝影、 電腦斷層掃描和 X 光等選擇性醫學影像。此外,疫情造成的經濟衰退導致醫療機構的預算受到限制,限制了對輻射劑量監測系統等新技術的投資,進一步影響了市場成長。
預計劑量計區隔在預測期內將是最大的
劑量計區隔估計佔據最大佔有率,因為它在監測醫護人員、接受放射治療的患者和放射科工作人員的輻射等級方面發揮著重要作用。劑量計用於環境監測,以評估空氣、水和土壤中的輻射等級,特別是在核能設施或污染場地附近的區域。此外,核能發電廠和其他工業環境中還使用劑量計來確保職業安全,以確保工人不會暴露在有害等級的輻射下,這也推動了該領域的發展。
醫療輻射劑量監測領域預計在預測期內年複合成長率最高。
醫療輻射劑量監測產業預計在預測期內將經歷最高的年複合成長率,因為它致力於開發工具和系統來準確測量和管理患者和醫護人員的輻射暴露。醫學影像技術在診斷和治療計畫中的使用越來越多,增加了世界各地醫療機構對輻射劑量監測解決方案的需求。此外,劑量監測技術的進步,例如與電子健康記錄(EHR)的整合以及與影像設備的互通性,推動市場成長。
由於醫療保健基礎設施的開拓、診斷成像需求的增加以及輻射安全意識的提高等因素,亞太地區在預測期內獲得了最大的市場佔有率。中國、印度、日本、韓國和澳洲等國家正大力投資醫院、診所和診斷中心等醫療設施。此外,該地區慢性病患病率的不斷上升和人口老化導致對醫學影像處理的需求不斷成長,推動了該地區的成長。
由於歐洲注重患者安全,預計在預測期內年複合成長率最高。醫療機構、研究機構和產業相關人員之間的合作推動輻射劑量監測的創新和技術進步。此外,醫療保健專業人員和患者對輻射暴露相關風險的認知不斷提高,也推動了對輻射劑量管理解決方案的需求。
According to Stratistics MRC, the Global Radiation Dose Market is growing at a CAGR of 13.2% during the forecast period. Radiation dose refers to the amount of energy absorbed by an object or organism when exposed to ionizing radiation. It is measured in units such as Gray (GY) or Sievert (SV). The dose is crucial in assessing the potential biological effects of radiation exposure. Different tissues and organs have varying sensitivities to radiation, so understanding the dose received is essential for evaluating risks and determining appropriate safety measures. Monitoring and controlling radiation dose are fundamental in medical diagnostics, therapy, industrial applications, and environmental protection to ensure safety and minimize potential harm.
According to the World Health Organization (WHO), in January 2023, nearly 1.0 billion people in low and middle-income countries were served by healthcare facilities with low or no electricity supply.
Growing awareness of radiation safety
Healthcare facilities are increasingly prioritizing radiation safety initiatives and investing in dose monitoring technologies to ensure compliance with regulatory standards and improve patient outcomes. Moreover, patients are becoming more proactive in advocating for their own safety during medical imaging procedures. This heightened awareness is driven by educational initiatives, regulatory guidelines, and advancements in public health communication, which are propelling this market expansion.
High cost of implementation
The need for specialized equipment and technologies to measure and monitor radiation doses is one of the primary cost factors. These devices can be expensive to acquire, and their maintenance and calibration further add to the ongoing costs. Additionally, ongoing costs for maintenance, calibration, and software updates further contribute to the financial burden. These expenses can strain already tight budgets, particularly in healthcare systems facing financial constraints or resource limitations that are hindering this market.
Technological advancements
Innovations in sensor technology, data analytics, and imaging software enable the development of more sophisticated radiation dose monitoring devices and systems. These technological developments not only enhance patient safety by minimizing unnecessary radiation exposure but also improve workflow efficiency and data management for healthcare providers. Furthermore, improvements in imaging software facilitate dose tracking and analysis, allowing for a comprehensive evaluation of radiation dose distribution within the body and boosting this market further.
Lack of awareness and education
The lack of awareness and education can lead to underutilization of radiation dose monitoring technologies, missed opportunities for dose optimization, and an increased risk of radiation-related adverse effects for patients and healthcare professionals. Furthermore, patients may not be adequately educated about the risks and benefits of medical imaging procedures involving ionizing radiation, thereby significantly deterring this market expansion.
Covid-19 Impact
The COVID-19 pandemic has had several negative impacts on the radiation dose market globally. One significant effect has been the disruption of routine healthcare services, including elective medical imaging procedures such as mammography, CT scans, and X-rays. Moreover, the economic downturn caused by the pandemic has led to budget constraints for healthcare institutions, limiting their ability to invest in new technologies, including radiation dose monitoring systems, further impacting market growth.
The dosimeters segment is expected to be the largest during the forecast period
The dosimeters segment is estimated to hold the largest share due to its crucial role in monitoring radiation levels for medical personnel, patients undergoing radiological procedures, and workers in radiology departments. These find applications in environmental monitoring to assess radiation levels in air, water, and soil, particularly in areas near nuclear facilities or contaminated sites. Moreover, in nuclear power plants and other industrial settings, dosimeters are utilized for occupational safety to ensure workers are not exposed to harmful levels of radiation, which is propelling this segment's growth.
The medical radiation dose monitoring segment is expected to have the highest CAGR during the forecast period
The medical radiation dose monitoring segment is anticipated to have highest CAGR during the forecast period due to its primary focus on developing tools and systems to accurately measure and manage radiation exposure to patients and healthcare professionals. With the increasing use of medical imaging techniques for diagnosis and treatment planning, there is a growing demand for radiation dose monitoring solutions in healthcare facilities worldwide. Furthermore, advancements in dose monitoring technology, such as integration with electronic health records (EHRs) and interoperability with imaging equipment, are driving market growth.
Asia Pacific commanded the largest market share during the extrapolated period owing to factors such as increasing healthcare infrastructure development, rising demand for diagnostic imaging procedures, and growing awareness regarding radiation safety. Countries like China, India, Japan, South Korea, and Australia are witnessing substantial investments in healthcare facilities, including hospitals, clinics, and diagnostic centers. Moreover, the prevalence of chronic diseases and the aging population in the region contribute to the rising demand for medical imaging procedures, which is driving this region's growth.
Europe is expected to witness highest CAGR over the projection period, owing to a strong focus on patient safety. Collaborations between healthcare institutions, research organizations, and industry players drive innovation and technological advancements in radiation dose monitoring. Furthermore, increasing awareness among healthcare professionals and patients regarding the risks associated with radiation exposure fuels the demand for radiation dose management solutions.
Key players in the market
Some of the key players in the Radiation Dose Market include Landauer, Inc., Ludlum Measurements, Inc., Mirion Technologies, Inc., Polimaster, Inc, Thermo Fisher Scientific Inc., Radiation Detection Company, Inc., Sun Nuclear Corporation, Biodex Medical Systems, Inc., Fuji Electric Co., Ltd. and Fluke Biomedical.
In March 2024, Thermo Fisher Scientific Inc., the world leader in serving science, announced the launch of a new CorEvitas syndicated clinical registry in generalized pustular psoriasis (GPP).
In February 2024, Thermo Fisher Scientific Inc launched the Thermo Scientific(TM) Dionex(TM) Inuvion(TM) Ion Chromatography (IC) system, helping to make ion analysis simpler and more intuitive for labs of all sizes.
Table Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.